On March 19, 2024, Dr. Joana Goncalves, the Chief Medical Officer of Cara Therapeutics, Inc. (the Company), informed the Company of her intention to resign from her role effective April 16, 2024, to pursue another opportunity. Dr. Goncalves will continue to serve as Chief Medical Officer through April 16, 2024, to assist with an orderly transition as her duties are assumed by other members of the senior management team. Dr. Goncalves's departure is not related to any disagreement with the Company.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.739 USD | +7.99% | +1.41% | -0.31% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.31% | 37.41M | |
-4.06% | 86.13B | |
+1.97% | 39.82B | |
+56.59% | 25.23B | |
-13.79% | 15.36B | |
-8.82% | 11.95B | |
-15.27% | 11.6B | |
-41.58% | 11.51B | |
+6.14% | 8.71B | |
-7.02% | 8.12B |
- Stock Market
- Equities
- CARA Stock
- News Cara Therapeutics, Inc.
- Cara Therapeutics, Inc. Announces Resignation of Dr. Joana Goncalves as Chief Medical Officer, Effective April 16, 2024